Skip to main content

Table 4 Socio-demographic and clinical factors associated with multiple adverse events

From: Adverse events in Chinese human immunodeficiency virus (HIV) patients receiving first line antiretroviral therapy

Characteristic at baseline

Case/n

Crude model

Adjusted model

OR(95%CI)

P

OR(95%CI)

P

Age, years

  < 50

364/428

1

 

2.54(0.76–8.51)

0.130

  ≥ 50

43/46

2.52(0.76–8.37)

0.131

1

 

Marital status

 Single/divorced/widowed

314/367

0.89(0.47–1.68)

0.723

  

 Married/common law marriage

93/107

1

   

Years of Education

  ≤ 9

75/88

0.94(0.49–1.81)

0.849

  

  > 9

332/386

1

   

BMI, kg/m2

  < 24

292/351

1

 

1

 

  ≥ 24

115/123

2.91(1.35–6.27)

0.007

2.72(1.25–5.89)

0.012

CD4+, cells/mm3

  ≤ 199

102/120

1

   

 200–349

119/145

0.81(0.421.56)

0.524

  

 350–499

110/124

1.39(0.66–2.93)

0.392

  

  ≥ 500

76/85

1.49(0.64–3.50)

0.360

  

Viral load, cells/ml

  < 100,000

327/382

1

   

  ≥ 100,000

80/92

1.12(0.57–2.19)

0.738

  

Syphilis Status

 Yes

129/149

1.09(0.62–1.92)

0.763

  

 No

278/325

1

   

Hepatitis Status

Positive

25/31

0.67(0.26–1.69)

0.391

  

Negative

382/443

1

   

WHO Clinical Stage

 I + II

374/433

1

   

 III + IV

33/41

0.65(0.29–1.48)

0.651

  

Pre-existing AE

 Yes

346/403

1.00(0.48–2.06)

0.989

  

 No

61/71

1

   

Pre-existing multiple AE

 Yes

150/167

1.72(0.96–3.08)

0.071

1.57(0.86–2.84)

0.139

 No

257/307

1

 

1

 

Pre-existing severe AE

 Yes

33/36

1.88(0.56–6.32)

0.306

  

 No

374/438

1

  Â